IT1224142B - Forma delta cristallina, stabile, anidra di idrocloruro di prazosin e nuovo procedimento per la preparazione di detta forma delta cristallina - Google Patents

Forma delta cristallina, stabile, anidra di idrocloruro di prazosin e nuovo procedimento per la preparazione di detta forma delta cristallina

Info

Publication number
IT1224142B
IT1224142B IT23292/84A IT2329284A IT1224142B IT 1224142 B IT1224142 B IT 1224142B IT 23292/84 A IT23292/84 A IT 23292/84A IT 2329284 A IT2329284 A IT 2329284A IT 1224142 B IT1224142 B IT 1224142B
Authority
IT
Italy
Prior art keywords
delta
crystalline
stable
preparation
new procedure
Prior art date
Application number
IT23292/84A
Other languages
English (en)
Italian (it)
Other versions
IT8423292A0 (it
Inventor
Stig Olof Engelbert Lindholm
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IT8423292A0 publication Critical patent/IT8423292A0/it
Application granted granted Critical
Publication of IT1224142B publication Critical patent/IT1224142B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IT23292/84A 1984-06-25 1984-10-24 Forma delta cristallina, stabile, anidra di idrocloruro di prazosin e nuovo procedimento per la preparazione di detta forma delta cristallina IT1224142B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (2)

Publication Number Publication Date
IT8423292A0 IT8423292A0 (it) 1984-10-24
IT1224142B true IT1224142B (it) 1990-09-26

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23292/84A IT1224142B (it) 1984-06-25 1984-10-24 Forma delta cristallina, stabile, anidra di idrocloruro di prazosin e nuovo procedimento per la preparazione di detta forma delta cristallina

Country Status (17)

Country Link
US (2) US4739055A (Direct)
JP (1) JPS6115881A (Direct)
AT (1) AT389117B (Direct)
AU (1) AU566814B2 (Direct)
BE (1) BE900925A (Direct)
CH (1) CH661045A5 (Direct)
DE (1) DE3429415A1 (Direct)
FI (1) FI79107C (Direct)
FR (1) FR2567124B1 (Direct)
GB (1) GB2160861B (Direct)
IL (1) IL73267A (Direct)
IT (1) IT1224142B (Direct)
LU (1) LU85616A1 (Direct)
NL (1) NL8403250A (Direct)
NZ (1) NZ209962A (Direct)
PT (1) PT79411B (Direct)
ZA (1) ZA85910B (Direct)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
DK1953162T3 (da) * 2001-02-24 2012-09-10 Boehringer Ingelheim Pharma Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel.
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
UA97244C2 (en) 2006-05-04 2012-01-25 Берингер Ингельхайм Интернациональ Гмбх Polymorphs of 1-((4-methyfquinazolin-2-yl)methyl)-3-methyl-7- (2-butyn-1-yl)-8-(3-(r)-aminopiperidin-l-yl)xanthine
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) * 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
KR101610005B1 (ko) * 2007-08-17 2016-04-08 베링거 인겔하임 인터내셔날 게엠베하 Ｆａｂ 관련 질환의 치료에 사용하기 위한 푸린 유도체
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
CA2735562C (en) * 2008-08-15 2017-10-17 Boehringer Ingelheim International Gmbh Dpp-4 inhibitors for wound healing
MX2011002558A (es) 2008-09-10 2011-04-26 Boehringer Ingelheim Int Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP3646859A1 (en) 2009-11-27 2020-05-06 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
CN102946875A (zh) 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
KR102391564B1 (ko) 2016-06-10 2022-04-29 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴 및 메트포르민의 병용물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156532C (Direct) *
US2969375A (en) * 1961-01-24 Certification of correction
NL54420C (Direct) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
AU3451084A (en) 1986-01-02
GB8424999D0 (en) 1984-11-07
FR2567124B1 (fr) 1990-09-21
CH661045A5 (de) 1987-06-30
IL73267A0 (en) 1985-01-31
US4873330A (en) 1989-10-10
JPH0481993B2 (Direct) 1992-12-25
GB2160861B (en) 1987-11-18
FI842544A0 (fi) 1984-06-25
GB2160861A (en) 1986-01-02
AT389117B (de) 1989-10-25
FI79107B (fi) 1989-07-31
IL73267A (en) 1988-06-30
DE3429415A1 (de) 1986-01-02
AU566814B2 (en) 1987-10-29
JPS6115881A (ja) 1986-01-23
ATA344184A (de) 1989-03-15
LU85616A1 (fr) 1985-06-04
FI842544L (fi) 1985-12-26
US4739055A (en) 1988-04-19
PT79411A (en) 1984-11-01
FI79107C (fi) 1989-11-10
BE900925A (fr) 1985-02-15
IT8423292A0 (it) 1984-10-24
NZ209962A (en) 1987-06-30
DE3429415C2 (Direct) 1990-05-03
ZA85910B (en) 1985-09-25
PT79411B (en) 1986-09-15
NL8403250A (nl) 1986-01-16
FR2567124A1 (fr) 1986-01-10

Similar Documents

Publication Publication Date Title
IT1224142B (it) Forma delta cristallina, stabile, anidra di idrocloruro di prazosin e nuovo procedimento per la preparazione di detta forma delta cristallina
IT1176856B (it) Metodo per la sintesi di iodobenzene
IT1176981B (it) Metodo per la sintesi di iodobenzene
IT8521763A0 (it) Procedimento per la preparazione di derivati 3-sostituiti dall'1-amino-2-idrossi-propano.
IT1184730B (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine
IT1200719B (it) Apparacchiatura per la crescita di monocristalli
IT1183883B (it) Procedimento per la preparazione di amminoidrossicefamcarbossilati
IT1187681B (it) Metodo per la preparazione di 3,4-epossibutirrati alchilici
DK687188A (da) Fremgangsmaade til fremstilling af 2,2'-oxodisuccinat
IT1187655B (it) Procedimento per la preparazione di w-lattami,in particolare caprolattame
IT1176376B (it) Procedimento per la preparazione di 3, 11-dimepil-2-nonacosanone
IT8509479A0 (it) Macchina per la fabbricazione di cialde cave
IT8621066A1 (it) Procedimento per la preparazione di composti eterociclici azotati
IT1180216B (it) Procedimento per la preparazione di l-fenilalaninametilestere cloridrato
DK160819C (da) Fremgangsmaade til fremstilling af 3,5-dichlor-2-pyridon
IT1175989B (it) Procedimento per la preparazione di polifenileteri
IT1178793B (it) Procedimento per la preparazione di 3,4,5-trimetossi-benzonitrile
IT1246377B (it) Procedimento per la fabbricazione di monocristalli di periclasio
IT8321578A1 (it) Processo per la preparazione di 3,3'- 0 3,4 - diamminobenzofenone
KR860004840A (ko) N, n'-비스테레프탈아미드의 제조방법
UA26015A1 (uk) Спосіб одержаhhя похідhих 2,5-дихлорфеhолу
IT8467696A0 (it) Procedimento per la preparazione di polioli
IT1184680B (it) Procedimento per la fabbricazione di polvere bordolese
KR840008349A (ko) 2, 3-비히드로-2, 2-디메틸-7-벤조푸라놀의 제조방법
IT1177468B (it) Procedimento per la preparazione di 3,5-etano-2,4-dodecadienoati

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941028